These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

495 related articles for article (PubMed ID: 15194768)

  • 1. Biological analysis of human immunodeficiency virus type 1 R5 envelopes amplified from brain and lymph node tissues of AIDS patients with neuropathology reveals two distinct tropism phenotypes and identifies envelopes in the brain that confer an enhanced tropism and fusigenicity for macrophages.
    Peters PJ; Bhattacharya J; Hibbitts S; Dittmar MT; Simmons G; Bell J; Simmonds P; Clapham PR
    J Virol; 2004 Jul; 78(13):6915-26. PubMed ID: 15194768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV-1 R5 Macrophage-Tropic Envelope Glycoprotein Trimers Bind CD4 with High Affinity, while the CD4 Binding Site on Non-macrophage-tropic, T-Tropic R5 Envelopes Is Occluded.
    Quitadamo B; Peters PJ; Repik A; O'Connell O; Mou Z; Koch M; Somasundaran M; Brody R; Luzuriaga K; Wallace A; Wang S; Lu S; McCauley S; Luban J; Duenas-Decamp M; Gonzalez-Perez MP; Clapham PR
    J Virol; 2018 Jan; 92(2):. PubMed ID: 29118121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV-1 tropism for the central nervous system: Brain-derived envelope glycoproteins with lower CD4 dependence and reduced sensitivity to a fusion inhibitor.
    Martín-García J; Cao W; Varela-Rohena A; Plassmeyer ML; González-Scarano F
    Virology; 2006 Mar; 346(1):169-79. PubMed ID: 16309726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variation of macrophage tropism among HIV-1 R5 envelopes in brain and other tissues.
    Peters PJ; Dueñas-Decamp MJ; Sullivan WM; Clapham PR
    J Neuroimmune Pharmacol; 2007 Mar; 2(1):32-41. PubMed ID: 18040824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variation in HIV-1 R5 macrophage-tropism correlates with sensitivity to reagents that block envelope: CD4 interactions but not with sensitivity to other entry inhibitors.
    Peters PJ; Duenas-Decamp MJ; Sullivan WM; Brown R; Ankghuambom C; Luzuriaga K; Robinson J; Burton DR; Bell J; Simmonds P; Ball J; Clapham PR
    Retrovirology; 2008 Jan; 5():5. PubMed ID: 18205925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-macrophage-tropic human immunodeficiency virus type 1 R5 envelopes predominate in blood, lymph nodes, and semen: implications for transmission and pathogenesis.
    Peters PJ; Sullivan WM; Duenas-Decamp MJ; Bhattacharya J; Ankghuambom C; Brown R; Luzuriaga K; Bell J; Simmonds P; Ball J; Clapham PR
    J Virol; 2006 Jul; 80(13):6324-32. PubMed ID: 16775320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The V1-V3 region of a brain-derived HIV-1 envelope glycoprotein determines macrophage tropism, low CD4 dependence, increased fusogenicity and altered sensitivity to entry inhibitors.
    Rossi F; Querido B; Nimmagadda M; Cocklin S; Navas-Martín S; Martín-García J
    Retrovirology; 2008 Oct; 5():89. PubMed ID: 18837996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood monocytes harbor HIV type 1 strains with diversified phenotypes including macrophage-specific CCR5 virus.
    Xu Y; Zhu H; Wilcox CK; van't Wout A; Andrus T; Llewellyn N; Stamatatos L; Mullins JI; Corey L; Zhu T
    J Infect Dis; 2008 Jan; 197(2):309-18. PubMed ID: 18173363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macrophage tropism of human immunodeficiency virus type 1 isolates from brain and lymphoid tissues predicts neurotropism independent of coreceptor specificity.
    Gorry PR; Bristol G; Zack JA; Ritola K; Swanstrom R; Birch CJ; Bell JE; Bannert N; Crawford K; Wang H; Schols D; De Clercq E; Kunstman K; Wolinsky SM; Gabuzda D
    J Virol; 2001 Nov; 75(21):10073-89. PubMed ID: 11581376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macrophage entry mediated by HIV Envs from brain and lymphoid tissues is determined by the capacity to use low CD4 levels and overall efficiency of fusion.
    Thomas ER; Dunfee RL; Stanton J; Bogdan D; Taylor J; Kunstman K; Bell JE; Wolinsky SM; Gabuzda D
    Virology; 2007 Mar; 360(1):105-19. PubMed ID: 17084877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Varied tropism of HIV-1 isolates derived from different regions of adult brain cortex discriminate between patients with and without AIDS dementia complex (ADC): evidence for neurotropic HIV variants.
    Smit TK; Wang B; Ng T; Osborne R; Brew B; Saksena NK
    Virology; 2001 Jan; 279(2):509-26. PubMed ID: 11162807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Independent evolution of macrophage-tropism and increased charge between HIV-1 R5 envelopes present in brain and immune tissue.
    Gonzalez-Perez MP; O'Connell O; Lin R; Sullivan WM; Bell J; Simmonds P; Clapham PR
    Retrovirology; 2012 Mar; 9():20. PubMed ID: 22420378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioinformatic analysis of neurotropic HIV envelope sequences identifies polymorphisms in the gp120 bridging sheet that increase macrophage-tropism through enhanced interactions with CCR5.
    Mefford ME; Kunstman K; Wolinsky SM; Gabuzda D
    Virology; 2015 Jul; 481():210-22. PubMed ID: 25797607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in and discrepancies between cell tropisms and coreceptor uses of human immunodeficiency virus type 1 induced by single point mutations at the V3 tip of the env protein.
    Shimizu N; Haraguchi Y; Takeuchi Y; Soda Y; Kanbe K; Hoshino H
    Virology; 1999 Jul; 259(2):324-33. PubMed ID: 10388657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential CD4/CCR5 utilization, gp120 conformation, and neutralization sensitivity between envelopes from a microglia-adapted human immunodeficiency virus type 1 and its parental isolate.
    Martín J; LaBranche CC; González-Scarano F
    J Virol; 2001 Apr; 75(8):3568-80. PubMed ID: 11264346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV-1 non-macrophage-tropic R5 envelope glycoproteins are not more tropic for entry into primary CD4+ T-cells than envelopes highly adapted for macrophages.
    Musich T; O'Connell O; Gonzalez-Perez MP; Derdeyn CA; Peters PJ; Clapham PR
    Retrovirology; 2015 Mar; 12():25. PubMed ID: 25809903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macrophage-tropic simian/human immunodeficiency virus chimeras use CXCR4, not CCR5, for infections of rhesus macaque peripheral blood mononuclear cells and alveolar macrophages.
    Igarashi T; Donau OK; Imamichi H; Dumaurier MJ; Sadjadpour R; Plishka RJ; Buckler-White A; Buckler C; Suffredini AF; Lane HC; Moore JP; Martin MA
    J Virol; 2003 Dec; 77(24):13042-52. PubMed ID: 14645561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complex determinants in human immunodeficiency virus type 1 envelope gp120 mediate CXCR4-dependent infection of macrophages.
    Ghaffari G; Tuttle DL; Briggs D; Burkhardt BR; Bhatt D; Andiman WA; Sleasman JW; Goodenow MM
    J Virol; 2005 Nov; 79(21):13250-61. PubMed ID: 16227248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of naturally occurring basic amino acid substitutions in the human immunodeficiency virus type 1 subtype E envelope V3 loop on viral coreceptor usage and cell tropism.
    Kato K; Sato H; Takebe Y
    J Virol; 1999 Jul; 73(7):5520-6. PubMed ID: 10364300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Persistent CCR5 utilization and enhanced macrophage tropism by primary blood human immunodeficiency virus type 1 isolates from advanced stages of disease and comparison to tissue-derived isolates.
    Li S; Juarez J; Alali M; Dwyer D; Collman R; Cunningham A; Naif HM
    J Virol; 1999 Dec; 73(12):9741-55. PubMed ID: 10559284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.